NorthRock Partners’s Tenet Healthcare THC Stock Holding History

NorthRock Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,796	Closed	-$365K	–	887
2025 Q3	$365K	Buy	+1,796	New	+$319K	0.01%	639

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

NorthRock Partners's THC Position: Q4 2025 in Review

NorthRock Partners sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 1,796 shares — an estimated $365K sold.

NorthRock Partners first reported a position in THC in Q3 2025 and held it in 1 quarter. The position peaked at $365K in Q3 2025. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

NorthRock Partners reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
NorthRock Partners sold 1,796 Tenet Healthcare shares in Q4 2025, an estimated $365K.
NorthRock Partners first reported a position in Tenet Healthcare in Q3 2025 and held it in 1 quarter.
NorthRock Partners's Tenet Healthcare position peaked at $365K in Q3 2025.
705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.